Thrombosis (Blood Clots) Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Thrombosis and Anticoagulation Program

Children with thrombosis are treated through the Dana-Farber/Boston Children's Thrombosis and Anticoagulation ProgramAlan Michelson, MD, our program’s director, is an expert in the field of platelets and platelet disorders. He is the editor of Platelets, the field’s premier academic journal on these conditions. He also directs the Center for Platelet Research Studies, an internationally recognized, multi-disciplinary research center in thrombosis and anticoagulation.

The center’s researchers perform scientific and clinical research on platelets and related aspects of hemostasis and thrombosis. A particular focus is antiplatelet therapy, including the characterization of:

  • how newly discovered molecules and mechanisms could help control platelets and clotting
  • how antiplatelet drugs affect normal blood clotting (coagulation) and aspects of the immune system (e.g., inflammation)
  • the relationship between the strength of antiplatelet treatments and the balance between thrombosis (uncontrolled clotting) and hemorrhage (uncontrolled bleeding)
  • how tests of platelet function could help guide antiplatelet therapy in the clinic
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close